SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-026692
Filing Date
2024-02-07
Accepted
2024-02-07 16:12:56
Documents
16
Period of Report
2024-02-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d180813d8k.htm   iXBRL 8-K 29646
2 EX-99.1 d180813dex991.htm EX-99.1 16056
6 GRAPHIC g180813g0207153810961.jpg GRAPHIC 29213
  Complete submission text file 0001193125-24-026692.txt   220763

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sana-20240207.xsd EX-101.SCH 2828
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sana-20240207_lab.xml EX-101.LAB 18736
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sana-20240207_pre.xml EX-101.PRE 11692
17 EXTRACTED XBRL INSTANCE DOCUMENT d180813d8k_htm.xml XML 3772
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 24604418
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)